Human 20S-PA200 Proteasome Complex |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436; | 2×IHP; 2×K0W; | 6rey | 1-241 |
Assess |
human PA200-20S complex |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436; | 1×K0W; 1×IHP; | 6kwy | 1-241 |
Assess |
Human Constitutive 20S Proteasome |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | | 4r3o | 8-241 |
Assess |
Crystal Structure of the mammalian 20S proteasome at 2.75 A resolution |
Heteromer P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; | 30×MG; | 1iru | 8-241 |
Assess |
Human constitutive 20S proteasome in complex with carfilzomib |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 6×3BV; | 4r67 | 8-241 |
Assess |
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 4×ATP; 5×MG; 2×ADP; | 6msd | 8-241 |
Assess |
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | | 5vfo | 8-241 |
Assess |
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 2×ADP; 3×ATP; 3×MG; | 6msg | 8-241 |
Assess |
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 4×ATP; 4×MG; 1×ADP; | 6msj | 8-241 |
Assess |
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 4×AGS; | 5vfr | 8-241 |
Assess |
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 4×ATP; 5×MG; 1×ADP; | 6msk | 8-241 |
Assess |
Structural basis for dynamic regulation of the human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 4×ATP; 1×ZN; | 5t0j | 8-241 |
Assess |
Structural basis for dynamic regulation of the human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 6×ADP; 1×ZN; | 5t0h | 8-241 |
Assess |
SA-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… |
Heteromer A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG48; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 4×AGS; 5×MG; 2×ADP; | 6wjd | 8-241 |
Assess |
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; | 5vfu | 8-241 |
Assess |
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 4×ATP; 5×MG; 2×ADP; | 6msb | 8-241 |
Assess |
SD-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 4×AGS; | 6wjn | 8-241 |
Assess |
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; | 5vft | 8-241 |
Assess |
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 4×AGS; | 5vfq | 8-241 |
Assess |
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 3×ATP; 3×MG; 2×ADP; | 6mse | 8-241 |
Assess |
Human 20S proteasome bound to an engineered 11S (PA26) activator |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; Q9U8G2; | | 6xmj | 8-241 |
Assess |
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 3×ATP; 1×ADP; | 6msh | 8-241 |
Assess |
Structural basis for dynamic regulation of the human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 4×ATP; 1×ZN; | 5t0i | 8-241 |
Assess |
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 4×AGS; | 5vfp | 8-241 |
Assess |
Structural basis for dynamic regulation of the human 26S proteasome |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 6×ATP; 1×ZN; | 5t0g | 8-241 |
Assess |
Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 1×ZN; 6×AGS; | 5vfs | 8-241 |
Assess |
bovine 20S immunoproteasome |
Heteromer P33672; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; | | 7dr7 | 8-241 |
Assess |
Bovine 20S immunoproteasome in complex with two human PA28alpha-beta activators |
Heteromer P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46; | | 7drw | 8-241 |
Assess |
PA28alpha-beta in complex with immunoproteasome |
Heteromer P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46; | | 7dr6 | 8-241 |
Assess |
The human 26S proteasome at 3.9 A |
Heteromer O14818; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P49720; P49721; P60900; P62191; P62195; P62333; Q99436; | 5×ATP; 5×MG; 1×ADP; | 5l4g | 8-241 |
Assess |
Structure of the human 26S proteasome bound to USP14-UbAl |
Heteromer O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | 6×ADP; | 5gjq | 8-241 |
Assess |
Native human 20S proteasome at 1.8 Angstrom |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 57×CL; 9×1PE; 6×K; 10×MG; | 5le5 | 9-241 |
Assess |
Human 20S proteasome complex with Oprozomib at 1.9 Angstrom |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 58×CL; 6×K; 10×MG; 9×1PE; | 5ley | 9-241 |
Assess |
Human 20S proteasome complex with Delanzomib at 2.0 Angstrom |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 52×CL; 8×K; 10×MG; 9×1PE; 4×6V7; | 5lf4 | 9-241 |
Assess |
Human 20S proteasome complex with Ixazomib at 2.0 Angstrom |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 51×CL; 6×K; 10×MG; 9×1PE; 6×6V8; | 5lf7 | 9-241 |
Assess |
Human 20S proteasome complex with Dihydroeponemycin at 2.0 Angstrom |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 56×CL; 6×K; 10×MG; 9×1PE; 6×6VC; | 5lf1 | 9-241 |
Assess |
Human 20S proteasome complex with Z-LLY-ketoaldehyde at 2.1 Angstrom |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 55×CL; 6×K; 10×MG; 9×1PE; 2×PHQ; | 5lf6 | 9-241 |
Assess |
Human 20S proteasome complex with Bortezomib at 2.1 Angstrom |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 51×CL; 6×K; 10×MG; 9×1PE; 6×BO2; | 5lf3 | 9-241 |
Assess |
Human 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstrom |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 6×K; 10×MG; 9×1PE; 4×ACT; | 5lez | 9-241 |
Assess |
Native human 20S proteasome in Mg-Acetate at 2.2 Angstrom |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 6×K; 9×MG; 9×1PE; | 5lex | 9-241 |
Assess |
Human 20S proteasome complex with Epoxomicin at 2.4 Angstrom |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 58×CL; 6×K; 10×MG; 9×1PE; | 5lf0 | 9-241 |
Assess |
Mouse 20S immunoproteasome in complex with PR-957 |
Heteromer O09061; O35955; O70435; P28063; P28076; P49722; P99026; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; | 41×CL; 13×K; 6×04C; 6×IOD; | 3unf | 9-241 |
Assess |
Mouse constitutive 20S proteasome in complex with PR-957 |
Heteromer O09061; O55234; O70435; P49722; P70195; P99026; Q60692; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; | 6×04C; | 3unb | 9-241 |
Assess |
Mouse constitutive 20S proteasome |
Heteromer O09061; O55234; O70435; P49722; P70195; P99026; Q60692; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; | | 3une | 9-241 |
Assess |
Mouse 20S immunoproteasome |
Heteromer O09061; O35955; O70435; P28063; P28076; P49722; P99026; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; | 14×IOD; 23×CL; 10×K; | 3unh | 9-241 |
Assess |
Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively … |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900; | 2×BZ7; | 6avo | 9-241 |
Assess |
Endogeneous native human 20S proteasome |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | | 6r70 | 9-241 |
Assess |
Human 20S Proteasome |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | | 6rgq | 9-241 |
Assess |
Human 26S proteasome in complex with Oprozomib |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q15008; Q99436; Q99460; Q9UNM6; | 6×ADP; | 5m32 | 9-241 |
Assess |
Human Immunoproteasome 20S particle in complex with compound 1 |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900; | 3×SCN; 12×NA; 4×HUJ; | 6e5b | 9-240 |
Assess |
The human 26S Proteasome at 6.8 Ang. |
Heteromer O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; | | 5ln3 | 10-241 |
Assess |
Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core |
Heteromer O14818; P20618; P25786; P25787; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; | 6×KNM; | 5a0q | 13-236 |
Assess |